EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urolithin A Exhibits Antidepressant-like Effects by Modulating the AMPK/CREB/BDNF Pathway

Yaqian Di, Rui Xue, Xia Li, Zijia Jin, Hanying Li, Lanrui Wu, Youzhi Zhang iD, Lei An

Nutrients · 11.07.2025 · 17 (14) · 2294

DOI: 10.3390/nu17142294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.07.2025. Verfasst von Yaqian Di und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Geriatric Nutrition and Health, Beijing Technology and Business University, Ministry of Education, Beijing 100048, China. Hauptthemen laut MEDLINE: Antidepressive Agents, Brain-Derived Neurotrophic Factor, Cyclic AMP Response Element-Binding Protein, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Key Discipline Construction Project of National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Urolithin A (UA), a gut-derived metabolite of ellagitannins or ellagic acid, has recently gained attention for its potential benefits to brain health. The present research aimed to assess the antidepressant-like properties of UA in both in vitro and in vivo models and explored the molecular mechanisms underlying these effects.

Methods

We investigated the antidepressant effects and mechanisms of UA in a model of corticosterone-induced damage to PC12 cells and in a model of chronic socially frustrating stress.

Results

Our results demonstrate that UA treatment (5 and 10 μM) significantly alleviated cellular damage and inflammation in corticosterone (CORT)-treated PC12 cells. Furthermore, UA administration (50 and 100 mg/kg) significantly reduced immobility time in the mouse tail suspension test (TST) and forced swim test (FST), indicating its antidepressant-like activity. Additionally, treatment with UA led to the activation of the cAMP response element-binding protein (CREB)/brain-derived neurotrophic factor (BDNF) signaling cascade and triggered the activation of adenosine monophosphate-activated protein kinase (AMPK) during these processes. Importantly, pretreatment with AMPK-specific inhibitor Compound C abolished UA’s cytoprotective effects in PC12 cells, as well as its behavioral efficacy in the FST and TST, and its neurotrophic effects, highlighting the critical role of AMPK activation in mediating these effects. Furthermore, in the chronic social defeat stress (CSDS) mouse model, UA treatment (50 and 100 mg/kg) significantly alleviated depression-like behaviors, including reduced sucrose preference in the sucrose preference test, increased social avoidance behavior in the social interaction test, and anxiety-like behaviors, including diminished exploration, in the elevated plus maze test, suggesting the antidepressant-like and anxiolytic-like activities of UA. Moreover, UA treatment reversed elevated serum stress hormone levels, hippocampal inflammation, and the decreased AMPK/CREB/BDNF signaling pathway in the hippocampus of CSDS mice.

Conclusions

Together, these results provide compelling evidence for UA as a viable dietary supplement or therapeutic option for managing depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsBrain-Derived Neurotrophic FactorCyclic AMP Response Element-Binding ProteinAMP-Activated Protein KinasesCoumarinsDepressionAnimalsPC12 CellsRatsSignal TransductionMaleMiceCorticosteroneBehavior, AnimalStress, PsychologicalDisease Models, Animal

Stichwörter der Autor:innen

AMPKCREBdepressionsignaling pathwayurolithin A

Substanzen

Antidepressive AgentsBrain-Derived Neurotrophic FactorCyclic AMP Response Element-Binding ProteinAMP-Activated Protein KinasesCoumarins3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneCorticosterone

Autor:innen und Institutionen

  • Key Laboratory of Geriatric Nutrition and Health, Beijing Technology and Business University, Ministry of Education, Beijing 100048, China.
  • Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.

ORCID-Profile: Youzhi Zhang

Förderung

  • Traditional Chinese Medicine Key Discipline Construction Project of National Administration of Traditional Chinese Medicine

Zitieren

APA

Di, Y., Xue, R., Li, X., Jin, Z., Li, H., Wu, L., Zhang, Y., & An, L. (2025). Urolithin A Exhibits Antidepressant-like Effects by Modulating the AMPK/CREB/BDNF Pathway. Nutrients, 17(14), 2294. https://doi.org/10.3390/nu17142294

Vancouver

Di Y, Xue R, Li X, Jin Z, Li H, Wu L, et al. Urolithin A Exhibits Antidepressant-like Effects by Modulating the AMPK/CREB/BDNF Pathway. Nutrients. 2025;17(14):2294. doi:10.3390/nu17142294

BibTeX
@article{Di2025,
  author = {Di, Yaqian and Xue, Rui and Li, Xia and Jin, Zijia and Li, Hanying and Wu, Lanrui and Zhang, Youzhi and An, Lei},
  title = {Urolithin A Exhibits Antidepressant-like Effects by Modulating the AMPK/CREB/BDNF Pathway},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {2294},
  doi = {10.3390/nu17142294}
}
Kostenlos starten →